IQVIA signals beyond the news: 47+ signals from 7 sources
The latest IQVIA signal on this page is from Sep 29, 2026 (Patents): "IQVIA was granted a patent for persistent patient identification." The busiest sources: LinkedIn (15+), Website changes (15+) and Patents (5).
- Signals
- 47+
- Sources
- 7
- Last 90 days
- 40
- Latest
- Sep 29, 2026
Other signals · latest 10
Latest IQVIA signals by source
47+ signals for IQVIA across 7 sources.
Patents · Patent grant
IQVIA was granted a patent for persistent patient identification.
In September 2026 IQVIA patented a way to create consistent patient identifiers for healthcare providers managing records across clinical data systems.
- Patent title
- System and method for creation of persistent patient identification
- Grant date
- Sep 29, 2026
- Inventors
- Christopher Blum, Geoff Wall, John Giannouris
- Tech area
- health tech / medical informatics
Patents · Patent counsel
IQVIA Inc. uses Troutman Pepper Locke LLP as outside IP counsel.
Troutman Pepper Locke LLP is the attorney of record on IQVIA Inc.'s recent US patent work, including a grant in 2026-09.
- Law firm
- Troutman Pepper Locke LLP
- Law firm domain
- troutman.com
- Matter date
- Sep 29, 2026
Reddit · Layoffs
A former European employee of IQVIA reports the company is heavily outsourcing to South America and that they were laid off with only 12 minutes of warning.
Post: "Am I stupid if I reject a generous offer from IQVIA?"
- Subreddit
- r/clinicalresearch
- Upvotes
- 16
- Comments
- 36
- Sentiment
- Negative
Reddit · Customer feedback
Clinical research professionals describe IQVIA's hiring process as very difficult to penetrate without an internal referral, noting the company is extremely strict about candidates having exact...
Post: "Why is it impossible to get a job at ICON or IQVIA"
- Subreddit
- r/clinicalresearch
- Upvotes
- 64
- Comments
- 40
- Sentiment
- Negative
Web traffic · Traffic snapshot
iqvia.com received 1M monthly visits with traffic from 5 countries.
Emerging AI traffic at 1% (~13,068 visits). Top: chatgpt.com (70%), perplexity.ai (1%).
- Monthly visits
- 1,253,554
- Month over month
- -12.7%
- 3-month change
- +2.7%
- Global rank
- 35,746
Website changes · Product highlight
IQVIA added dedicated AI and commercialization solution pages to its website, emphasizing workflow automation, execution, and agent-based AI capabilities.
Added links for “See what IQVIA AI can do for you,” including “Agentic AI,” “Commercial agentic AI,” and “IQVIA.ai platform,” with descriptions covering workflow automation, planning, engagement, and execution.
- Page
- /
Web traffic · Sustained growth
iqvia.com shows sustained growth with 3 consecutive months of increases, up 23% overall to 1M.
Emerging AI traffic at 1.2% (~17,888 visits). Top: chatgpt.com (87%), perplexity.ai (7%), claude.ai (1%).
- Monthly visits
- 1,435,310
- Month over month
- +17.6%
- 3-month change
- +22.7%
- Global rank
- 29,402
LinkedIn
White paper discusses patient-reported treatment tolerability for regulatory and clinical decision-making.
Patient-reported treatment tolerability is becoming an increasingly important part of regulatory and clinical decision-making. Learn how sponsors can capture the patient perspective, support benefit-risk assessments, and strengthen trial design. Download the white paper here: https://lnkd.in/eNRnbbsb
- Likes
- 34
- Comments
- 1
- Tags
- Healthcare Technology, Compliance, Clinical Operations
Podcasts · Sponsorship
IQVIA sponsors The MM+M Podcast
We can unfragment more fragmented inventory than you may think. We can measure hard-to-find or low-incidence conditions in a very granular way more than you'd think. We're seeing brands really be receptive to the idea that everything in...
- Podcast
- The MM+M Podcast
- Episode
- Measurement everywhere: Promises, proof and the path forward, a podcast sponsored by IQVIA
Employee growth · Sales team growth
53 Sales employees (8.0% of company), stable year-over-year.
The Sales department currently has 53 employees out of 666 total (8.0%). The department is stable year-over-year, representing a change of approximately +0 employees.
- Department headcount
- 53
- Department growth, 1 year
- 0%
- Total headcount
- 666
- Company growth, 1 year
- 0%
Showing 10 of 47+ signals. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track IQVIA with the Signal API
One POST /v1/companies/enrich call with iqvia.com returns IQVIA signals from 14 more signal types (reddit-company, podcast-company, glassdoor-company and more), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{
"domain": "iqvia.com",
"signal_types": ["reddit-company","podcast-company","glassdoor-company",
"product-reviews","linkedin-post-company","twitter-company-posts",
"youtube-company","website-intelligence","patents-company",
"federal-contract-award","conference-speaker","hackernews",
"producthunt-launch","seo-traffic"],
"limit": 20
}'Same industry
Other signals at related companies
Questions about IQVIA other signals
What signals does Autobound track for IQVIA besides news and filings?
What are people saying about IQVIA online?
Has IQVIA been granted patents recently?
Source. Reddit, podcasts, Glassdoor, product reviews, LinkedIn, X, YouTube, company websites, patents, federal contracts, conference talks, Hacker News, Product Hunt, web traffic and employee growth, from the Signal API.
Method. The latest 15 signals per source from the last 12 months. Posts that do not name the company, replies, repeats and unreadable rows are removed. Traffic and headcount keep their newest measure.
Data as of .